0 CHECKOUT

PRODUCT FILTERS

REGION

227
147
147
124
124

COUNTRY

114
24
24
16
16

PRICE

101
272
515
1,148

PUBLISHED

258
310
547
1,148

PRODUCT TYPE

1,086
59
2
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Global and Chinese Retigabine Dihydrochloride (CAS 150812-13-8) Industry - 2016

The 'Global and Chinese Retigabine Dihydrochloride Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Retigabine Dihydrochloride industry...

Published:  January 2016
Price:  From

Global and Chinese Pregabalin (CAS 148553-50-8) Industry - 2016

The 'Global and Chinese Pregabalin Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Pregabalin industry with a focus on the Chinese...

Published:  January 2016
Price:  From

Global and Chinese Amantadine (CAS 768-94-5) Industry - 2016

The 'Global and Chinese Amantadine Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Amantadine industry with a focus on the Chinese...

Published:  January 2016
Price:  From

Global and Chinese Retigabin (CAS 150812-12-7) Industry - 2016

The 'Global and Chinese Retigabin Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Retigabin industry with a focus on the Chinese market....

Published:  January 2016
Price:  From

Global and Chinese Gabapentin (CAS 60142-96-3) Industry - 2016

The 'Global and Chinese Gabapentin Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Gabapentin industry with a focus on the Chinese...

Published:  January 2016
Price:  From

Global and Chinese Levetiracetam (CAS 102767-28-2) Industry - 2016

The 'Global and Chinese Levetiracetam Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Levetiracetam industry with a focus on the Chinese...

Published:  January 2016
Price:  From

Global and Chinese Levetiracetam Acid (CAS 103833-72-3) Industry - 2016

The 'Global and Chinese Levetiracetam Acid Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Levetiracetam Acid industry with a focus...

Published:  January 2016
Price:  From

Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Insomnia-API Insights

Summary Insomnia-API Insights, 2015 report provides Insomnia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the...

Published:  February 2016
Price:  From

Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  February 2016
Price:  From

Osteoporosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Osteoporosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Osteoporosis-API Insights

Summary Osteoporosis-API Insights, 2015 report provides Osteoporosis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea...

Published:  February 2016
Price:  From

Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  February 2016
Price:  From

Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights

Summary Neuro Endocrine (Carcinoid) Carcinoma- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Neuro Endocrine (Carcinoid) Carcinoma. The main objective of this...

Published:  February 2016
Price:  From

Post Menopausal Osteoporosis-Pipeline Insights

Summary Post Menopausal Osteoporosis- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Post Menopausal Osteoporosis. The main objective of this report to track competitor...

Published:  February 2016
Price:  From

Post Menopausal Osteoporosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Post Menopausal Osteoporosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

Published:  February 2016
Price:  From

Post Menopausal Osteoporosis-API Insights

Summary Post Menopausal Osteoporosis-API Insights, 2015 report provides Post Menopausal Osteoporosis drugs marketed details and API Manufacturers details across the globe along with the location....

Published:  February 2016
Price:  From

Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2016

“ Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Neuro Endocrine (Carcinoid) Carcinoma....

Published:  February 2016
Price:  From

Post Menopausal Osteoporosis-Pipeline Insights, 2016

“ Post Menopausal Osteoporosis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Post Menopausal Osteoporosis. The report covers...

Published:  February 2016
Price:  From

Post Menopausal Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Post Menopausal Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients